Disc Medicine, Inc. (IRON:NASDAQ) closed at $74.51 on October 23, 2026, down 0.69% on the day. The stock trades 25.1% below its 52-week high of $99.50 and 86.3% above its 52-week low of $40.00. Over the past year, it lost 13.0%. Disc Medicine, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, IRON closed higher on 118 days (47%). Its best day was October 19, 2026 (+38.86%) and its worst was February 13, 2026 (-21.91%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of innovative therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The firm's pipeline includes investigational product candidates that affect heme biosynthesis and iron metabolism.
Find more stocks like IRON with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.